https://scholars.lib.ntu.edu.tw/handle/123456789/627125
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Chen C.-J. | en-US |
dc.contributor.author | Yang L.-Y. | en-US |
dc.contributor.author | Chang W.-Y. | en-US |
dc.contributor.author | Huang Y.-C. | en-US |
dc.contributor.author | Chiu C.-H. | en-US |
dc.contributor.author | Shih S.-R. | en-US |
dc.contributor.author | Huang C.-G. | en-US |
dc.contributor.author | Kuan-Ying A. Huang | en-US |
dc.date.accessioned | 2023-01-11T07:22:26Z | - |
dc.date.available | 2023-01-11T07:22:26Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 2041-1723 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138146832&doi=10.1038%2fs41467-022-33146-7&partnerID=40&md5=d7848cf918c2c660c17037ab208542d5 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/627125 | - |
dc.publisher | Nature Research | - |
dc.relation.ispartof | Nature Communications | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19 | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1038/s41467-022-33146-7 | - |
dc.identifier.pmid | 36115850 | - |
dc.identifier.scopus | 2-s2.0-85138146832 | - |
dc.relation.journalvolume | 13 | - |
dc.relation.journalissue | 1 | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Immunology | - |
crisitem.author.orcid | 0000-0001-6891-6945 | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 免疫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。